Providers/Grant Support
Provided by EXCEL Continuing Education.
This activity is supported by an independent education grant from RECORDATI RARE DISEASES.
Credits Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1 Nursing Contact Hour
All other healthcare professionals completing this course will be given a statement of participation (non-physicians).
Target Audience
This activity is designed to meet the educational needs of emergency department HCPs, hospitalists, hepatologists, pain management specialists, geneticists, hematologists, and allied healthcare providers to improve their awareness and diagnosis of clinical manifestations of acute hepatic porphyrias.
Program Overview
The diagnosis of acute porphyric syndromes should be considered in many patients with otherwise unexplained intense abdominal pain, severe constipation, systemic arterial hypertension, or other characteristic symptoms that can be seen in the emergency department setting. Intensely painful attacks can be life-threatening if incorrectly diagnosed, representing a significant HCP knowledge and practice gap. Intravenous hemin therapy is the treatment of choice for all but mild attacks of the acute porphyrias and should be started as soon as possible. To close these practice gaps, our AHP expert will discuss treatment strategies and provide recommendations using real patient cases seen in the ED setting.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Discuss the clinical manifestations of AHP to prompt an earlier diagnosis
- Recognize signs and symptoms of AHP in the ED setting: neurovisceral and other acute symptoms
- Using sample patient cases, employ strategies to manage attacks in the ED setting
Faculty
Akshata Moghe, MD, PhD
Assistant Professor, Department of Internal Medicine
Division of Gastroenterology, Hepatology, and Nutrition
University of Texas Health Science Center
Houston, TX
Accreditation Statement
EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
PHYSICIANS: EXCEL Continuing Education designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES: EXCEL Continuing Education is accredited by the Florida Board of Nursing, Provider # 50-619 and designates this activity for 1 nursing contact hour.
Disclosures of Conflict of Interest
Name: Akshata Moghe, MD, PhD
Dr. Moghe has indicated that she is a paid speaker/consultant with Recordati Rare Diseases and Alnylam Pharmaceuticals.
EXCEL staff and the peer reviewer have nothing to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
EXCEL Continuing Education requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected].